News
EZH2 may be therapeutic target for multiple myeloma
Preclinical research published in Oncotarget has provided new insights regarding how the protein EZH2 affects the development of multiple myeloma...
News
Considering cattle could help fight malaria
The goal of eliminating malaria in countries like India could be more achievable if mosquito-control efforts take into account the relationship...
News
Bank could help docs identify optimal AML treatment, team says
Research published in Nature Genetics suggests a knowledge bank can reveal the optimal treatment for patients with acute myeloid leukemia (AML...
News
HAIs in kids are most common among infants, study shows
Data from hospitals in 29 European countries suggest that healthcare-associated infections (HAIs) reported in children occur most often in infants...
News
Drug could treat IDA in patients with NDD CKD
Results of a phase 3 trial suggest oral ferric citrate could be an alternative to intravenous iron for treating iron deficiency anemia (IDA) in...
News
FDA issues CRL for IV formulation of antiemetic agent
The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) regarding the new drug application (NDA) for an intravenous...
News
Approach may provide better treatment of GVHD, team says
Preclinical research suggests that targeting 2 kinases may provide an approach to treating graft-vs-host-disease (GVHD) that does not compromise...
News
FDA warns against use of ‘anticancer’ product
The US Food and Drug Administration (FDA) is warning consumers not to purchase or use PNC-27, a product being promoted and sold through PNC27.com...
News
Malaria infection depends on number of parasites in mosquitoes
Mosquitoes carrying a greater number of malaria-causing parasites may be more likely to cause infection, according to a study published in PLOS...
News
Blood and plasma screening system gets CE mark
Abbott’s Alinity s System for blood and plasma screening has received the CE mark and is now available for use in countries that recognize the...
News
Venetoclax approved to treat CLL in Australia
The Australian Therapeutic Goods Administration (TGA) has approved the BCL-2 inhibitor venetoclax (Venclexta™, formerly ABT-199) for use in...
News
Intervention may improve warfarin management
Researchers have developed an intervention intended to help hospitals and clinicians improve the management of patients on warfarin. The team...
News
NCI launches program to expedite drug research
The National Cancer Institute (NCI) has launched a new drug formulary designed to provide investigators at NCI-designated cancer centers with...
News
Predicting response to cytarabine in AML patients
New research suggests the protein SAMHD1 could be used to predict which patients with acute myeloid leukemia (AML) will respond to treatment...
News
Team uses light to launch drugs from RBCs
Researchers say they’ve developed a technique that uses light to activate a drug stored in circulating red blood cells (RBCs) so the drug is...